Compare Gajah Tunggal Tbk. (GJTL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gajah Tunggal Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Gajah Tunggal Tbk. trades at Rp1,350 (market cap 4.67T, 4.86M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Gajah Tunggal Tbk. is far larger — about 44.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| GJTL | SCPI | |
|---|---|---|
Market Cap | 4.67T | 104.4B |
Volume | 4.86M | — |
Lot | 48.58K | — |
Turnover | 6.5B | — |
Average Price | 1,338.2 | — |
Value | 6.5B | — |
Indicative Equilibrium Price | 1,350 | — |
Indicative Equilibrium Volume | 602 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gajah Tunggal Tbk.
PT. Gajah Tunggal, Tbk (the Company) was established based on notarial deed No. 54 dated August 24, 1951 of Raden Meester Soewandi, S.H., notary public in Jakarta. The Company is the largest tire manufacturer in Indonesia with 32% market share of four-wheel vehicle tire market and 85% of the motorcycle tire market.
Read more on GJTL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
